1. Effect of Amiloride and Spironolactone on Renal Tubular Function and Central Blood Pressure in Patients with Arterial Hypertension during Baseline Conditions and after Furosemide: A Double-Blinded, Randomized, Placebo-Controlled Crossover Trial. (August 2013) Authors: Matthesen, Solveig K.; Larsen, Thomas; Vase, Henrik; Lauridsen, Thomas G.; Jensen, Janni M.; Pedersen, Erling B. Journal: Clinical and experimental hypertension Issue: Volume 35:Number 5(2013) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes. (January 2014) Authors: Mose, Frank H.; Larsen, Thomas; Jensen, Janni M.; Hansen, Annebirthe B.; Bech, Jesper N.; Pedersen, Erling B. Journal: Scandinavian journal of clinical & laboratory investigation Issue: Volume 74:Number 1(2014) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension. (5th June 2015) Authors: Mose, Frank H.; Jensen, Janni M.; Therwani, Safa; Mortensen, Jesper; Hansen, Annebirthe B.; Bech, Jesper N.; Pedersen, Erling B. Journal: British journal of clinical pharmacology Issue: Volume 80:Number 3(2015:Sep.) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗